HAP Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,100
Closed -$216K 1166
2022
Q4
$216K Sell
13,100
-200
-2% -$6.35K 0.02% 448
2022
Q3
$200K Sell
13,300
-1,600
-11% -$58.7K 0.01% 623
2022
Q2
$251K Buy
14,900
+3,500
+31% +$122K 0.01% 641
2022
Q1
$189K Sell
11,400
-60,300
-84% -$2.87M 0.01% 861
2021
Q4
$623K Buy
71,700
+57,700
+412% +$3.99M 0.02% 613
2021
Q3
$166K Sell
14,000
-184,000
-93% -$15.4M 0.01% 1100
2021
Q2
$1.28M Sell
198,000
-102,600
-34% -$8.72M 0.04% 385
2021
Q1
$424K Buy
300,600
+212,300
+240% +$21.1M 0.02% 542
2020
Q4
$89K Buy
+88,300
New +$7.04M ﹤0.01% 1216

Other funds holding ARKG

HAP Trading's ARKG Position: Q1 2023 in Review

HAP Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 15,502 shares — an estimated $438K sold.

HAP Trading first reported a position in ARKG in Q3 2019 and held it in 5 quarters. The position peaked at $2.27M in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • HAP Trading reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 15,502 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $438K.
  • HAP Trading first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 5 quarters.
  • HAP Trading's ARK Genomic Revolution ETF position peaked at $2.27M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.